VaxGen's AIDS Vaccine to Be Reviewed by FDA

Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.

VaxGen's AIDS Vaccine to Be Reviewed by FDA

New York Times (12.17.02) - Tuesday, December 17, 2002
Reuters

VaxGen Inc. said yesterday that the Food and Drug Administration had agreed to an accelerated review of its experimental AIDS vaccine. VaxGen is testing the vaccine for preventing HIV infection in a pivotal stage, or phase III, trial among 5,400 people in the United States, Canada, the Netherlands and Puerto Rico. The company said it expects to announce preliminary results in the first quarter of 2003. Another pivotal-stage trial of a vaccine version intended to fight HIV subtypes prevalent in Southeast Asia is being conducted in Thailand, and those results are expected in the second half of next year.
021217
AD022441

Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.